Adalimumab for Nail Psoriasis: Efficacy and Safety From the Open-Label Extension of a Phase-3, Randomized, Placebo-Controlled Trial

Authors

Alice Gottlieb, New York Medical CollegeFollow
B Elewski
M Okun
J Bagel
Y Poulin
Y Gu
D Williams
W Valdecantos

Document Type

Abstract

Publication Date

June 2017

Journal Title

Journal of the American Academy of Dermatology

Department

Dermatology

Recommended Citation

Gottlieb, A., Elewski, B., Okun, M., Bagel, J., Poulin, Y., Gu, Y., Williams, D., & Valdecantos, W. (2017). Adalimumab for Nail Psoriasis: Efficacy and Safety From the Open-Label Extension of a Phase-3, Randomized, Placebo-Controlled Trial. Journal of the American Academy of Dermatology, 76 (6 Suppl. 1), AB33. Retrieved from https://touroscholar.touro.edu/nymc_fac_abstracts/44